PCA3-based nomogram for predicting prostate cancer and high grade cancer on initial transrectal guided biopsy

Elshafei A., Chevli K. K., Moussa A. S., Kara Ö., Chueh S., Walter P., ...More

PROSTATE, vol.75, no.16, pp.1951-1957, 2015 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 75 Issue: 16
  • Publication Date: 2015
  • Doi Number: 10.1002/pros.23096
  • Journal Name: PROSTATE
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.1951-1957
  • Keywords: PCA3 nomogram, prostate cancer, prostate biopsy, ANTIGEN 3, VALIDATION, PCA3, MANAGEMENT, MORTALITY, ASSAY, RISK, GENE, MEN
  • Kocaeli University Affiliated: No

Abstract

BACKGROUNDTo develop a validated prostate cancer antigen 3 (PCA3) based nomogram that predicts likelihood of overall prostate cancer (PCa) and intermediate/high grade prostate cancer (HGPCa) in men pursuing initial transrectal prostate biopsy (TRUS-PBx).